Literature DB >> 3243821

Determination of benazepril, a new angiotensin-converting enzyme inhibitor, and its active metabolite, benazeprilat, in plasma and urine by capillary gas chromatography-mass-selective detection.

A Sioufi1, F Pommier, G Kaiser, J P Dubois.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3243821     DOI： 10.1016/0378-4347(88)80082-3

Source DB:  PubMed          Journal:  J Chromatogr


× No keyword cloud information.
  5 in total

1.  Mass spectral fragmentation reactions of angiotensin-converting enzyme (ACE) inhibitors.

Authors:  David J Burinsky; Scott L Sides
Journal:  J Am Soc Mass Spectrom       Date:  2004-09       Impact factor: 3.109

Review 2.  Benazepril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and congestive heart failure.

Authors:  J A Balfour; K L Goa
Journal:  Drugs       Date:  1991-09       Impact factor: 9.546

3.  The effects of age on the pharmacokinetics and pharmacodynamics of single oral doses of benazepril and enalapril.

Authors:  N J Macdonald; A Sioufi; C A Howie; J R Wade; H L Elliott
Journal:  Br J Clin Pharmacol       Date:  1993-09       Impact factor: 4.335

4.  A comparison in young and elderly subjects of the pharmacokinetics and pharmacodynamics of single and multiple doses of benazepril.

Authors:  N J Macdonald; H L Elliott; D M Hughes; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1993-09       Impact factor: 4.335

5.  Pharmacokinetics and pharmacodynamics of benazepril hydrochloride in patients with major proteinuria.

Authors:  C Schweizer; G Kaiser; W Dieterle; J Mann
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.